Business
Biohit Oyj: Kari Syrjänen resigns as Chair of the Board of Directors
Biohit Oyj: Kari Syrjänen resigns as Chair of the Board of
About this update from Biohit Oyj Class B
English Finnish Published: 2026-09-02 16:00:00 CEST Biohit Oyj - Changes board/management/auditors Biohit Oyj: Kari Syrjänen resigns as Chair of the Board of Directors Biohit Oyj Biohit Oyj: Kari Syrjänen resigns as Chair of the Board of Directors Biohit Oyj Stock Exchange Release 2.9.2026 at 5:00 p.m. (EEST) The Chair of the Board of Directors of Biohit Oyj, Kari Syrjänen, has announced his resignation from the Board of Directors with effect from 2 September 2026. The resignation is due to personal reasons. The Board of Directors has elected current Board member Kalle Härkönen as its new Chair. Additional information: Jussi Hahtela, CEO, Biohit Oyj, tel. +358 50 383 5948 [email protected] www.biohithealthcare.com Biohit in brief Biohit Oyj is a globally operating Finnish biotechnology company. Biohit's mission is "Innovating for Health" - we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com Company News Subscribe European Market Activity Nasdaq Europe © 2026, Nasdaq, Inc. All Rights Reserved.
View stock analysis, news, and events for Biohit Oyj Class B